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The US Veterans Health Administration (VHA) engaged in quality improvement targeting vascular risk factors 
including hypertension, hyperlipidemia, and diabetes melli-
tus.1 As a result, vascular risk factor control has improved in 
VHA hospitals.2 Data from 2012 demonstrated that the aver-
age VHA facility pass rate was 78.5% for achieving a blood 
pressure (BP) of <140/90 mm Hg.2
In contrast to high levels of current performance, a study of 
the VHA from a decade ago evaluated BP and LDL (low-density 
lipoprotein) cholesterol after carotid endarterectomy, coronary 
artery bypass grafting, and percutaneous coronary intervention3 
finding that cerebrovascular disease patients were less likely to 
achieve control than cardiovascular disease patients. Specifically, 
the proportion of patients undergoing carotid endarterectomy 
with optimal control of both BP and LDL cholesterol increased 
from 23% to 33% after the procedure compared with increases 
from 32% to 43% for coronary artery bypass grafting and 29% 
to 45% for percutaneous coronary intervention.
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Background and Purpose—The Veterans Health Administration has engaged in quality improvement to improve vascular risk 
factor control. We sought to examine blood pressure (<140/90 mm Hg), lipid (LDL [low-density lipoprotein] cholesterol 
<100 mg/dL), and glycemic control (hemoglobin A1c <9%), in the year post-hospitalization for acute ischemic stroke or 
acute myocardial infarction (AMI).
Methods—We identified patients who were hospitalized (fiscal year 2011) with ischemic stroke, AMI, congestive heart 
failure, transient ischemic attack, or pneumonia/chronic obstructive pulmonary disease. The primary analysis compared 
risk factor control after incident ischemic stroke versus AMI. Facilities were included if they cared for ≥25 ischemic 
stroke and ≥25 AMI patients. A generalized linear mixed model including patient- and facility-level covariates compared 
risk factor control across diagnoses.
Results—Forty thousand two hundred thirty patients were hospitalized (n=75 facilities): 2127 with incident ischemic 
stroke and 4169 with incident AMI. Fewer stroke patients achieved blood pressure control than AMI patients (64%; 95% 
confidence interval, 0.62–0.67 versus 77%; 95% confidence interval, 0.75–0.78; P<0.0001). After adjusting for patient 
and facility covariates, the odds of blood pressure control were still higher for AMI than ischemic stroke patients (odds 
ratio, 1.39; 95% confidence interval, 1.21–1.51). There were no statistical differences for AMI versus stroke patients in 
hyperlipidemia (P=0.534). Among patients with diabetes mellitus, the odds of glycemic control were lower for AMI than 
ischemic stroke patients (odds ratio, 0.72; 95% confidence interval, 0.54–0.96).
Conclusions—Given that hypertension control is a cornerstone of stroke prevention, interventions to improve poststroke 
hypertension management are needed.   (Stroke. 2018;49:296-303. DOI: 10.1161/STROKEAHA.117.017142.)
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On the basis of these prior data from the VHA3 and simi-
lar data from non-VHA settings,4,5 we conducted the present 
study to compare the quality of BP control, lipid control, and 
glycemic control in the 1 year after an index hospitalization 
for ischemic stroke versus acute myocardial infarction (AMI) 
and examine postevent outpatient utilization for patients with 
ischemic stroke versus AMI. In secondary analysis, we exam-
ined the quality of risk factor control among patients with 
hospitalization for transient ischemic attack (TIA), congestive 
heart failure (CHF), and pneumonia/chronic obstructive pul-
monary disease (COPD) exacerbation.
Methods
Design and Data
We identified patients with a hospitalization in fiscal year 2011 at 
a VHA facility for 1 of 5 conditions: AMI, ischemic stroke, TIA, 
CHF, or pneumonia/COPD exacerbation. We chose these diagnoses 
because they are clinically important, common, and represent 3 dis-
tinct categories: cerebrovascular events (stroke and TIA), cardiovas-
cular events (AMI and CHF), and nonvascular events (pneumonia/
COPD exacerbation). We collected VHA data on risk factor control 
and healthcare utilization during the 1-year preindex event and the 
1 year post-discharge. We used VHA data sets for demographic 
data and International Classification of Diseases, Ninth Revision, 
(Clinical Modification) diagnostic and procedure information to iden-
tify inpatient and outpatient encounters. We collected laboratory, vital 
signs, and outpatient clinic visit data from the VHA Corporate Data 
Warehouse. We obtained dates of death from VA vital status files. 
We received human subjects and VHA Research and Development 
committee approvals. The data that support the findings of this study 
are stored on VHA servers; investigators interested in using the data 
described in these analyses should contact the corresponding author.
Population
Patients with a discharge diagnosis code (Table I in the online-only 
Data Supplement) from any VHA facility for ischemic stroke, TIA, 
AMI, CHF, or pneumonia/COPD exacerbation were included. The 
first admission (fiscal year 2011) was identified as the index hospital-
ization. Patients who were admitted to a non-VHA facility for their 
index hospitalization were not included. Patients were classified as 
either primary or secondary based on the primary or secondary dis-
charge diagnosis, respectively. Patients with ischemic stroke and AMI 
were further classified as having either an incident (new) or a recur-
rent event based. Incident events were identified for patients without 
any inpatient or outpatient codes for that specific diagnosis in the 
previous 5 fiscal years. The primary analysis focused on patients with 
an incident ischemic stroke based on a primary diagnosis and patients 
with an incident AMI based on a primary diagnosis. A distinct cat-
egory labeled vascular combination included patients with hospital-
izations for ischemic stroke or TIA, and AMI or CHF. Patients were 
excluded if they died within the first 90 days post-discharge because 
our focus was posthospitalization vascular risk factor control and 
patients who died early post-discharge had limited opportunity for 
risk factor management. Facilities were included if they cared for ≥25 
patients with incident ischemic stroke and ≥25 patients with incident 
AMI. Because the initial focus of our analysis was the evaluation of 
quality of care at the facility level, low-volume sites were excluded 
using methods similar to other studies of facility-level quality; the 
inherent uncertainty in observed rates because of small sample size 
can impair the comparisons across facilities.6,7
Outpatient Clinics
Using the methods used in VHA quality assessments, we identified 
outpatient visits where vascular risk factor management is likely to 
occur (Table I in the online-only Data Supplement).8 We classified 
the clinics as primary care (primary care, general internal medicine, 
geriatrics, geriatrics primary care, and women’s clinic); cardiology; 
and neurology or other specialty care (endocrine, diabetes mellitus, 
hypertension, infectious disease, pulmonary/chest, and renal/nephrol-
ogy). Patients were assigned to the facility where they had the major-
ity of their clinic visits in the 1 year post-discharge.8 If there was an 
equal number of postdischarge clinic visits at ≥2 facilities or if there 
were no clinic visits, the patient was assigned to their index hospi-
talization facility. No minimum or maximum delay from discharge 
to the last clinic visit was imposed; all observed, eligible clinic visit 
data were used.
Vascular Risk Factor Control Outcomes
Facility risk factor control was estimated as the proportion of patients 
with target control level for each individual risk factor in the year 
post-hospitalization (pass rate). The use of electronic health record 
data for the assessment of vascular risk factor control has been evalu-
ated in prior studies finding excellent agreement between electronic 
health record data and chart review.9,10
Hypertension
For the hypertension assessment, all patients were included as eli-
gible. BP measurements taken at any eligible clinic (described above) 
were included; measurements taken in an Emergency Department, 
inpatient setting, or other outpatient clinics (eg, podiatry) were 
excluded. If multiple BP values were present on 1 day, we used the 
lowest value for that date. The average of all BP measurements for 
each patient was calculated in the 1 year post-discharge; no minimum 
or maximum number of BP measurements was required for this cal-
culation. Passing was defined as an average systolic BP <140 mm Hg 
and an average diastolic BP <90 mm Hg.
Hyperlipidemia
All patients were considered eligible for lipid control; patients with 
the last LDL cholesterol <100 mg/dL in the 1-year postdischarge 
period were classified as passing.
Diabetes Mellitus
Patients with diabetes mellitus were eligible for glycemic control. 
After the standard used for the VHA performance measure for diabe-
tes mellitus control, patients with an hemoglobin A1c (HbA1c) <9%11 
(based on the last measurement available) were classified as passing.
Covariates
Baseline characteristics at the time of index hospitalization included 
age, sex, and comorbidities. Diagnostic codes from 5 fiscal years 
before the index hospitalization, from both the inpatient and outpatient 
settings, were used to identify patient comorbidities. Comorbidities 
included the 5 conditions that defined the index hospitalization and 
diabetes mellitus, hypertension, or hyperlipidemia. A comorbidity 
was considered present on the basis of 1 inpatient code or 2 outpatient 
codes.12 The Charlson comorbidity index was calculated.13
Analyses
The primary patient-level analysis evaluated the difference in vascu-
lar risk factor control between patients with incident AMI versus inci-
dent ischemic stroke; statistical comparisons in patient characteristics 
between these 2 groups were conducted using 2-sided independent t 
tests and χ2 tests.
A generalized linear mixed model (GLMM) including patient- and 
facility-level covariates was used to compare all diagnoses on each 
of the 3 risk factor control outcomes.14 Patient covariates included 
sex, age, Charlson comorbidity, history of diabetes mellitus (except 
in model for glycemic control), history of hyperlipidemia, history of 
hypertension, and number of clinic visits by type (eg, primary care, 
cardiology, neurology), and risk factor control before index event 
(mean systolic BP, last LDL cholesterol, or last HbA1c). Facility-
level covariates included primary care quality2 and geographic region 
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effect was included to account for correlation of patients from the 
same facility. The intraclass correlation (ICC) of each risk factor was 
estimated from a model which included only the facility-level random 
intercept. The ICC from the final model including all patient- and 
facility-level covariates was also estimated, and the percent of vari-
ability in facility-level risk factor control explained by the patient- 
and facility-level covariates was reported.
Multiple imputation, with 10 imputations (predictive mean match-
ing method, SAS Proc MI), was used to impute the mean systolic 
BP for the BP model, the last LDL cholesterol value for the lipid 
model, and the last HbA1c value for the diabetes mellitus model. For 
example, the mean systolic BP was imputed by randomly selecting 
1 of the 5 observed values whose predicted values were closest to 
the predicted value for the missing value from the simulated regres-
sion model. The GLMM was fit to each of the 10 imputed data sets 
for each outcome. The population-adjusted risk factor control and 
95% confidence intervals (CIs) for all diagnostic groups and the odds 
ratios (ORs) and associated 95% CIs were estimated by combining 
the model results which takes into account the additional uncertainty 
because of the imputation.15 ORs were estimated with continuous 
covariates set at their mean.
The focus of the analysis was initially at the facility level. 
Therefore, we began the primary analyses by visually comparing 
differences in risk factor control across facilities between diagno-
ses. These figures were used to determine whether disparities in 
care between ischemic stroke and AMI patients were more evident 
at facilities providing suboptimal care. Facilities were sorted by 
the pass rates for the incident AMI population in ascending order 
(increased quality of care over the x axis). The observed propor-
tion of patients who passed the measure at each facility was plotted 
along with a 95% exact (Clopper–Pearson) confidence interval (CI). 
For the ischemic stroke population, the facilities were placed in the 
order defined by the AMI population, and the proportion of patients 
with incident ischemic stroke who passed the measure was similarly 
plotted with the 95% CIs. In addition, we included horizontal lines 
to represent the overall mean and 95% CIs for the measure across 
facilities. For each figure, medical centers were arbitrarily labeled; 
thus, sites cannot be compared across figures.
Sensitivity Analyses
We conducted 3 sensitivity analyses to evaluate the BP control 
results. To examine the impact of missing data on the estimation of 
the ORs, we imputed the BP outcome with fully conditional specifi-
cation logistic regression in addition to the predictive mean match-
ing imputation used for the covariate of mean systolic BP before 
index event. To verify that the difference in hypertension control 
between ischemic stroke and AMI patients was not dependent on 
whether the patient was cared at an ischemic stroke-serving facility, 
we created an indicator for facilities serving >50 ischemic stroke 
patients per year. We then built a GLMM for hypertension control 
including a random facility effect and additional fixed effects for 
diagnostic group, stroke serving (yes/no), and the 2-way interac-
tions. To assess whether the disparity in BP control (ischemic stroke 
versus AMI) might be partially because of how patients were clas-
sified into diagnostic categories, we reran the primary model and 
reported the ORs from the new model with ischemic stroke patients 
placed in the vascular combination group.
Results
Fifty-five thousand four hundred thirteen patients were hos-
pitalized for 1 of the 5 diagnoses at 130 facilities. Seven 
thousand four hundred ninety-three patients died within 90 
days after the index hospitalization. Another 7690 patients 
were excluded because they were hospitalized at the 55 
facilities with <25 ischemic stroke and AMI patients (Figure 
I in the online-only Data Supplement). Our analytic cohort 
included 40 230 patients who received care at 75 facilities 
(Table 1). Among 4141 ischemic stroke patients, 2127 had 
an incident stroke. Among 9575 AMI patients, 4169 had an 
incident AMI.
Patients with incident ischemic stroke were older (mean±SD, 
67.3±10.8 years versus 65.7±11.1 years; P<0.0001), were less 
likely to have a history of hypertension (70.6% versus 74.6%; 
P<0.001), hyperlipidemia (54.3% versus 68.9%; P<0.0001), 
and diabetes mellitus (34.3% versus 38.6%; P=0.001) com-
pared with incident AMI patients (Table 2).
Hypertension
Incident AMI patients had more BP measurements in the 1 year 
post-discharge than incident ischemic stroke patients: mean 
number of BP measurements, 5.6 (range, 0–197; median, 5.0; 
interquartile range, 4.0; SD, 5.3) versus 4.7 (range, 0–154; 
median, 4.0; interquartile range, 4.0; SD, 5.3; P<0.0001).
From the GLMM with patient-level BP control as the out-
come and a random facility intercept term only, the ICC was 
estimated to be 0.013 (random intercept=0.044). From the 
Table 1. Final Diagnostic Classification
Diagnostic Classification
n=40 230 Patients  
75 Facilities (%)
Primary analysis
  Incident stroke 2127 (5.3)
  Incident AMI 4169 (10.4)
Secondary analysis
  Secondary diagnosis incident or recurrent 
ischemic stroke
2014 (5.0)
  Secondary diagnosis incident or recurrent AMI 5406 (13.4)
  CHF 11 265 (28.0)
  TIA 1233 (3.1)
  Chronic obstructive pulmonary disease or 
pneumonia
7579 (18.8)
  Vascular combination (stroke/TIA and AMI/CHF) 6437 (16.0)
Total 40 230 (100)
AMI indicates acute myocardial infarction; CHF, congestive heart failure; TIA, 
transient ischemic attack.












Male, n (%) 2064 (97.0) 4064 (97.5) 0.302
Hypertension, n (%) 1501 (70.6) 3110 (74.6) <0.001
Hyperlipidemia, n (%) 1156 (54.3) 2873 (68.9) <0.0001
Diabetes mellitus, 
n (%)
730 (34.3) 1607 (38.6) 0.001
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Table 3. Multivariable Model (GLMM) for Vascular Risk Factor Control
Covariates
Hypertension Control*;  
n=37 188 Patients
LDL Cholesterol Control†;  
n=31 367 Patients
Glycemic Control‡;  
n=15 978 Patients
OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value
Patient level
  Primary analysis (reference: incident stroke)
   Incident AMI 1.39 (1.21–1.59) <0.0001 1.05 (0.91–1.21) 0.534 0.72 (0.54–0.96) 0.028
  Secondary analysis
   Secondary incident or recurrent AMI 1.52 (1.33–1.74) <0.0001 0.83 (0.72–0.96) 0.011 0.59 (0.45–0.78) 0.0002
   Secondary incident or recurrent stroke 1.14 (0.98–1.33) 0.109 0.72 (0.61–0.85) 0.0002 1.00 (0.71–1.42) >0.999
   TIA 1.09 (0.91–1.3) 0.352 0.59 (0.49–0.71) <0.0001 0.90 (0.59–1.37) 0.631
   CHF 1.48 (1.31–1.67) <0.0001 0.67 (0.59–0.77) <0.0001 0.65 (0.50–0.84) 0.001
   COPD/pneumonia 1.31 (1.16–1.48) <0.0001 0.46 (0.40–0.53) <0.0001 0.96 (0.72–1.28) 0.762
   Vascular combination 1.26 (1.11–1.43) 0.0004 0.79 (0.69–0.91) 0.0009 0.75 (0.57–0.98) 0.036
  Age 1.01 (1.01–1.01) <0.0001 1.02 (1.02–1.02) <0.0001 1.03 (1.02–1.04) <0.0001
  Female sex 1.18 (1.01–1.38) 0.046 0.70 (0.60–0.81) <0.0001 1.12 (0.83–1.52) 0.458
  Charlson comorbidity index 1.00 (0.99–1.01) 0.482 1.01 (0.99–1.03) 0.181 1.01 (0.99–1.03) 0.228
  History of diabetes mellitus 0.90 (0.85–0.95) 0.0003 1.35 (1.27–1.44) <0.0001 …  
  History of hypertension 0.58 (0.53–0.63) <0.0001 1.20 (1.11–1.30) <0.0001 1.16 (0.94–1.44) 0.181
  History of hyperlipidemia 1.21 (1.13–1.29) <0.0001 0.79 (0.74–0.85) <0.0001 0.81 (0.69–0.95) 0.009
  Risk factor control in the year before the 
index event
Mean BP systolic  
(5 points); 0.73 (0.72–0.74)
<0.0001
Last LDL (10 points); 
0.81 (0.80–0.82)
<0.0001
Last A1c (1 point); 
0.57 (0.55–0.59)
<0.0001
  No. of primary visits (year post-event) 1.00 (0.99–1.01) 0.304 1.00 (0.99–1.01) 0.316 0.99 (0.98–1.00) 0.056
  No. of cardiology visits (year post-event) 1.07 (1.06–1.08) <0.0001 1.04 (1.03–1.05) <0.0001 1.01 (0.99–1.03) 0.107
  No. of neurology/other visits  
(year post-event)
0.98 (0.97–0.99) 0.002 1.02 (1.01–1.03) 0.005 0.98 (0.96–1.00) 0.005
Facility level (75 facilities)
  Primary care vascular risk factor control 
(0.10 U change)§
1.16 (0.98–1.38) 0.101 1.29 (1.09–1.53) 0.003 1.36 (1.11–1.67) 0.003
  VAMC region (reference: West)
   Caribbean 1.33 (0.94–1.89) 0.117 1.14 (0.82–1.59) 0.436 0.81 (0.58–1.12) 0.210
   Midwest 0.92 (0.81–1.05) 0.213 0.99 (0.87–1.13) 0.875 0.99 (0.85–1.16) 0.914
   Northeast 0.98 (0.83–1.16) 0.856 0.98 (0.83–1.16) 0.804 0.96 (0.79–1.17) 0.666
   South 0.93 (0.83–1.04) 0.215 0.99 (0.89–1.10) 0.919 1.00 (0.87–1.14) 0.979
  Random facility intercept (σ2
F
) 0.019 (SE=0.0063) 0.002 0.016 (SE=0.0054) 0.002 … …
  Random intercept/(random intercept+π2/3) ICC=0.006 … ICC=0.005 … … …
AMI indicates acute myocardial infarction; BP, blood pressure; CHF, congestive heart failure; CI, confidence interval; COPD, chronic obstructive pulmonary disease; 
GLMM, generalized linear mixed model; ICC, intraclass correlation; LDL, low-density cholesterol; OR, odds ratio; TIA, transient ischemic attack; VAMC, Department of 
Veterans Affairs Medical Center; and VHA, Veterans Health Administration.
*The hypertension control model results were reported with covariates set at means: facility-level risk control, 0.7744; age, 68.7, Charlson, 1.266; primary visits, 
5.231; cardiology visits, 1.702; neuro/other visits, 1.476; and mean BP systolic year prior, 132.03. Multiple imputation was used for the mean systolic blood pressure 
in the year before the index event.
†The lipid control model results were reported with covariates set at means: facility-level risk control, 0.775; age, 68.4, Charlson, 1.274; primary visits, 5.387; 
cardiology visits, 1.805; neuro/other visits, 1.517; and last LDL, 90.36. Multiple imputation was used for the last LDL cholesterol before the index event.
‡The glycemic control model results were reported with covariates set at means: facility-level risk control, 0.775; age, 68.9, Charlson, 1.836; primary visits, 5.387; 
cardiology visits, 1.805; neuro/other visits, 1.517; and last HbA1c, 7.47%. The random intercept term was removed (<0.0003). Multiple imputation was used for the 
last HbA1c before the index event.
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fully-adjusted model, the ICC was reduced to 0.006 (random 
intercept=0.019). Therefore, ≈57% (0.025/0.044) of the vari-
ability in facility-level BP control was explained by the patient- 
and facility-level covariates. Mean systolic BP before index 
event was imputed for 7% of patients (2602/37 188) using mul-
tiple imputation. From the GLMM, the odds of achieving BP 
control were higher for incident AMI than for incident ischemic 
stroke patients (OR, 1.39; 95% CI, 1.21–1.59) after adjusting 
for patient- and facility-level covariates (Table 3). Comparisons 
of adjusted-mean BP control demonstrated that the best BP 
control (red line, Figure) was among patients with a secondary 
new or recurrent AMI (0.86; 95% CI, 0.85–0.88) and the worst 
(green line, Figure) was for incident ischemic stroke patients 
(0.81; 95% CI, 0.78–0.83). Overall, patients with recurrent/sec-
ondary incident AMI, CHF, incident AMI, and COPD/pneumo-
nia were similar with regard to BP control and were at the better 
end of the spectrum, whereas patients with recurrent/second-
ary incident ischemic stroke, TIA, and incident ischemic stroke 
were at the worse end of the spectrum (Figure).
From the GLMM model that included the random facility-
level intercept only, the mean pass rate for BP control for 
incident ischemic stroke was 64.4% (95% CI, 62.0%–66.8%) 
versus 76.7% for incident AMI (95% CI, 75.1%–78.3%; 
Table 4). In the fully-adjusted analysis, the mean BP control 
pass rates were also lower for the incident ischemic stroke 
patients, 80.6% (95% CI, 78.1%–82.9%), compared with 
the incident AMI patients, 85.3% (95% CI, 83.4%–86.9%; 
Table 4). At 65 of 75 facilities (87%), the proportion of AMI 
patients with BP control was greater than the proportion of 
stroke patients with BP control (Figure II in the online-only 
Data Supplement). A relatively stable difference between 
ischemic stroke versus AMI pass rates was observed across 
the spectrum of facilities from lower performing (Figures II 
through IV, left, in the online-only Data Supplement) to higher 
performing sites (Figures II through IV, right, in the online-
only Data Supplement) across each of the 3 risk factors.
Results of sensitivity analyses (Table II in the online-only 
Data Supplement) provide evidence that the difference in 
BP control for incident ischemic stroke versus incident AMI 
patients was not influenced by missing BP values, whether 
the ischemic stroke and TIA patients were categorized with 
the incident stroke group or vascular combination groups, or 
whether patients were cared for at stroke-serving facilities.
Hyperlipidemia
From the GLMM with patient-level lipid control as the out-
come and a random facility intercept term only, the ICC was 
estimated to be 0.012 (random intercept=0.041). From the 
fully-adjusted model, the ICC was reduced to 0.005. Thus, 
≈61% of the variability in facility-level lipid control was 
explained by the patient and facility-level covariates. The last 
LDL before index event was imputed for 13.9% of patients 
(4354/31 367). The odds of achieving LDL cholesterol control 
were similar for incident AMI and incident ischemic stroke 
patients (OR, 1.05; 95% CI, 0.91–1.21) after adjusting for 
patient- and facility-level covariates (Table 3). Patients from 
all other diagnostic categories had worse LDL cholesterol 
control than incident ischemic stroke patients (Table 3).
No differences in observed facility-level hyperlipid-
emia control for incident ischemic stroke versus incident 
AMI patients were observed (Figure III in the online-only 
Data Supplement). Hyperlipidemia control rates were low-
est among patients with pneumonia/COPD exacerbation 
(Table 4). A key finding was that 468 of 2127 (22.0%) of the 
new ischemic stroke patients had no LDL measurement 1 year 
post-discharge compared with 528 of 4169 (12.7%) of new 
AMI patients without an LDL measurement (P<0.0001; Table 
III in the online-only Data Supplement).
Diabetes Mellitus
The facility ICC for HbA1c control was 0.005. However, after 
adjusting for patient- and facility-level covariates, the random 
intercept term was found to be negligible and removed from 
the model. The last HbA1c before index event was imputed 
for 5% of patients (796/15 978) using multiple imputation. 
The odds of achieving HbA1c control were lower for incident 
AMI patients compared with incident ischemic stroke patients 
(OR, 0.72; 95% CI, 0.54–0.96) after adjusting for patient- and 
facility-level covariates (Table 3).
Overall, observed facility-level glycemic control was similar 
for incident ischemic stroke patients and incident AMI patients 
(Figure IV in the online-only Data Supplement). Across the 5 
diseases, the adjusted diabetes mellitus pass rates were relatively 
similar, but the lowest rate was for secondary incident/recur-
rent AMI and the highest rate was for incident stroke (Table 4). 
Missing HbA1c values post-discharge were more common 
among incident ischemic stroke patients (90/730 [12.3%]) 
than incident AMI patients (153/1607 [9.5%]; P=0.039; Table 
III in the online-only Data Supplement).
Healthcare Utilization
Overall, 6% (n=2429) of patients did not have a clinic visit 
within the 1-year postindex hospitalization period. The mean 
time from hospital discharge to the last clinic visit for incident 
AMI patients was 282.5 days (range, 1–365 days; median, 
313.0 days; interquartile range, 101.0 days; SD, 84.8 days) 
and was 268.5 days for patients with incident ischemic stroke 
(range, 4–365 days; median, 300.0 days; interquartile range, 
115.0 days; SD, 92.3 days).
Incident AMI patients had more outpatient visits than inci-
dent stroke patients both pre- and post-hospitalization: mean 
of 4.9±4.8 visits (median 4) 1 year pre-hospitalization versus 
Figure. The diagnostic categories are listed from the highest 
blood pressure (BP) control on the left to the lowest on the right. 
Estimations were obtained from generalized linear mixed model 
(GLMM) using multiple imputation methods. Hypertension control 
for diagnostic groups connected by lines is not significantly dif-
ferent after adjusting for multiple comparisons with Sidak adjust-
ment. AMI indicates acute myocardial infarction; CHF, congestive 
heart failure; COPD, chronic obstructive pulmonary disease; and 
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mean of 3.9±3.8 visits (median 3; P<0.0001). Similarly, inci-
dent AMI patients had a mean of 7.9±6.1 visits (median 7) 
post-discharge, whereas incident stroke patients had a mean 
of 6.0±4.5 visits (median 5) post-discharge (P<0.0001). The 
primary difference in postdischarge outpatient utilization was 
increased cardiology visits for AMI patients (2.5 cardiol-
ogy visits per patient versus 0.4 visits per patient; P<0.0001; 
Table 5). On the basis of the adjusted GLMM models, cardi-
ology visits were associated with improved BP control (OR, 
1.07; 95% CI, 1.06–1.08), primary care visits were not asso-
ciated with BP control (OR, 1.00; 95% CI, 0.99–1.01), and 
neurology clinic visits were associated with worse BP control 
(OR, 0.98; 95% CI, 0.97–0.99; Table 3). A similar pattern 
was observed for glycemic control (Table 3). In contrast, both 
cardiology visits and neurology visits were associated with 
improved LDL cholesterol control (Table 3).
Pre-Event Hypertension Control
Secondary analyses were conducted to explore possible causes 
of the observed differences in hypertension control. Incident 
stroke patients (n=1725) had higher mean BP values before their 
index event compared with incident AMI patients (n=3662): 
139.7/79.1 (±17.5/11.8) mm Hg versus 134.6/76.5 (±15.1/10.7) 
mm Hg (t test P<0.0001 for diastolic blood pressure and SBP). 
Table 4. Vascular Risk Factor Control for Patients After Ischemic Stroke and Myocardial Infarction 
(n=75 Facilities)
Diagnostic Category*
Partially Adjusted† Fully Adjusted‡
Mean 95% CI Mean 95% CI
Blood pressure control (n=37 188 patients)
  Incident AMI 0.767 (0.751–0.783) 0.853 (0.834–0.869)
  Incident stroke 0.644 (0.620–0.668) 0.806 (0.781–0.829)
  Secondary incident/recurrent AMI 0.804 (0.790–0.817) 0.863 (0.846–0.879)
  Secondary incident/recurrent stroke 0.706 (0.681–0.729) 0.825 (0.801–0.847)
  TIA 0.723 (0.695–0.750) 0.819 (0.791–0.844)
  CHF 0.789 (0.777–0.800) 0.861 (0.845–0.875)
  COPD/pneumonia 0.777 (0.764–0.790) 0.844 (0.827–0.86)
  Vascular combination 0.747 (0.733–0.762) 0.840 (0.821–0.857)
LDL cholesterol control (n=31 367 patients)
  Incident AMI 0.751 (0.734–0.767) 0.810 (0.788–0.829)
  Incident stroke 0.723 (0.699–0.745) 0.802 (0.776–0.826)
  Secondary incident/recurrent AMI 0.803 (0.789–0.816) 0.770 (0.746–0.793)
  Secondary incident/recurrent stroke 0.718 (0.693–0.742) 0.746 (0.715–0.775)
  TIA 0.652 (0.62–0.683) 0.704 (0.667–0.739)
  CHF 0.768 (0.756–0.78) 0.732 (0.708–0.754)
  COPD/pneumonia 0.616 (0.599–0.633) 0.650 (0.622–0.676)
  Vascular combination 0.786 (0.772–0.799) 0.762 (0.738–0.784)
HbA1c control (n=15 978 patients)
  Incident AMI 0.835 (0.815–0.854) 0.891 (0.865–0.913)
  Incident stroke 0.836 (0.805–0.863) 0.919 (0.893–0.939)
  Secondary incident/recurrent AMI 0.826 (0.810–0.840) 0.870 (0.843–0.893)
  Secondary incident/recurrent stroke 0.875 (0.848–0.897) 0.919 (0.892–0.940)
  TIA 0.885 (0.849–0.913) 0.911 (0.875–0.937)
  CHF 0.852 (0.841–0.863) 0.881 (0.857–0.901)
  COPD/pneumonia 0.888 (0.872–0.902) 0.915 (0.895–0.932)
  Vascular combination 0.855 (0.842–0.868) 0.895 (0.872–0.914)
AMI indicates acute myocardial infarction; CHF, congestive heart failure; CI, confidence interval; COPD, chronic obstructive 
pulmonary disease; LDL, low-density cholesterol; and TIA, transient ischemic attack.
*The vascular combination category includes patients with hospitalizations for stroke, TIA, AMI, or CHF.
†Partially-adjusted means were obtained from generalized linear mixed model (GLMM) including only diagnostic category and 
random facility-level intercept.
‡Fully-adjusted means were obtained from the results of 10 imputations with GLMM and included patient/facility-level covariates 
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Stroke patients similarly had higher BP values after the index 
event: 134.2/76.8 (±15.1/10.0) mm Hg versus 128.7/73.4 
(±14.4/9.8) mm Hg (P<0.0001 for diastolic blood pressure and 
SBP). Stroke patients versus AMI patients were more likely to 
have both worsening of control (pass pre-event and fail post-
event: 10.1% versus 8.2%; P<0.0001) and improving con-
trol (fail pre-event and pass post-event: 23.7% versus 20.8%; 
P<0.0001; Table IV in the online-only Data Supplement). The 
relative disparity in observed hypertension control for AMI 
patients compared with ischemic stroke patients before the 
index event (63.9%−51.2%=12.7%) was similar to the relative 
disparity after the index event (76.6%−63.9%=12.6%).
Discussion
These results demonstrate that hypertension control is worse 
for patients with cerebrovascular disease than cardiovascu-
lar disease, although gaps in care exist for both populations. 
When comparing our results to prior reports from the VHA,3 
Canada,4 and France,5 3 key findings are apparent: risk fac-
tor control has improved considerably over time; risk factor 
control improves after hospitalization compared with prein-
dex event hospitalization; and although disparities in BP con-
trol continue to be present between ischemic stroke and AMI 
patients, lipid control rates were similar for stroke and AMI 
patients and diabetes mellitus control rates were lower for 
AMI than ischemic stroke patients.
One hypothesis for why cerebrovascular disease patients may 
have worse hypertension control compared with cardiovascular 
patients is that cardiologists caring for the latter are comfortable 
with hypertension management, whereas neurologist may not 
be comfortable titrating medications and primary care providers 
may wait for instructions from neurology. Uncontrolled BP has 
been demonstrated in one third to half of poststroke patients8,16,17 
and poststroke clinical inertia exists such that treatment inten-
sification does not occur at least 35% of visits with elevated 
BPs among poststroke patients.8 Stroke patients are more likely 
to receive monotherapy for hypertension than AMI patients.5 
Future studies should assess whether lack of care coordination, 
discomfort with risk factor modification by neurologists, or 
fear of overtreating hypertension by primary care providers 
may contribute to inadequate BP control poststroke.
Another potential explanation for our results is that stroke 
patients have more severe hypertension than patients with 
other diseases. The observation that stroke patients had higher 
BP pre-hospitalization provides support for this hypothesis. 
Given the absence of pharmacy data, we cannot assess the 
degree to which ischemic stroke patients’ pre-event hyper-
tension was because of disease severity, reduced medication 
adherence, or undertreatment. Prior research suggests that 
both poor adherence and undertreatment exist poststroke8; 
however, the degree to which these vary for AMI versus isch-
emic stroke patients is unknown.
It may also be that post-AMI patients routinely receive 
β-blockers which lower BP, and, therefore, post-AMI patients 
are more likely than poststroke patients to achieve BP con-
trol.1 Because we did not have medication data, we could not 
examine whether differences in antihypertensives may con-
tribute to disparities in postevent BP control.
Risk factor control rates for patients with CHF and the vas-
cular combination were similar to rates for AMI patients, sug-
gesting that care by cardiologists may be a shared mechanism 
for risk factor management. Control for patients with pneu-
monia/COPD exacerbations varied across the risk factors. 
We expected that risk factor control for TIA would have been 
similar to ischemic stroke, but found that the TIA rates were 
higher than ischemic stroke rates for BP and lower than stroke 
for both lipid control and diabetes mellitus control.
The strengths of this study were its large sample size, 
national scope, and inclusion of a range of causes of index 
hospitalization. Limitations of this study included the lack of 
medication data which could have been used to assess dis-
ease severity, patient adherence, and provider behavior (iner-
tia and medication management practices); the reliance on the 
VHA electronic health record data, which albeit robust for 
the assessment of laboratory data and vital signs9,10,18 lacks 
the details of chart review data which might have provide 
insight into the judgment of clinicians; and the lack of stroke 
subtype information. This study evaluated care for Veterans 
in VHA hospitals; therefore, these results might not general-
ize to other healthcare settings or populations (ie, women). 
Given the observational cohort design of this study, the esti-
mate of vascular risk factor control is based on available data 
and potential bias may be related to heterogeneity in measure-
ments between groups. Our assessment of vascular risk fac-
tor quality depends on patients having BP, LDL cholesterol, 
and HbA1c measurements in the electronic health record data. 
For this reason, we examined the difference in healthcare uti-
lization between incident AMI patients and incident ischemic 
stroke patients because observed differences in clinic visits 
(both frequency and timing) might provide insight into the 
Table 5. Outpatient Visits in Year After Hospitalization for Ischemic Stroke or Acute Myocardial Infarction
Clinic
Incident Acute Myocardial Infarction (n=4169) Incident Ischemic Stroke (n=2127)
No. of Visits
Proportion of 
Visits Mean Per Patient±SD No. of Visits
Proportion  
of Visits Mean Per Patient±SD
Primary care 19 216 58.6% 4.6±3.9 9077 71.2% 4.3±3.4
Cardiology 10 281 31.4% 2.5±3.5 889 7.0% 0.4±1.0
Neurology 510 1.6% 0.1±0.5 1786 14.0% 0.8±1.1
Other 2766 8.4% 0.7±1.7 995 7.8% 0.5±1.4
Total
32 773 100%
7.9±6.1; Range: 0.0–58.0; 
Median: 7.0; IQR: 6.0
12 747 100%
6.0±4.5; Range: 0.0–37.0; 
Median: 5.0; IQR: 5.0
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observed difference in vascular risk factor control in general 
and BP control, in particular. This study used single defini-
tions of passing for each process of care; future studies should 
examine the degree to which the results might vary based 
on alternative definitions (eg, prescription of high/moderate 
potency statin versus an LDL cholesterol <100 mg/dL).
In conclusion, these results demonstrate clinically substan-
tial disparities in hypertension control among patients with 
ischemic stroke versus patients with AMI. Given the observa-
tion that AMI patients receive more outpatient visits than isch-
emic stroke patients and that these additional visits are with 
cardiology, it may be that cardiologists provide risk factor 
management to the AMI patients that ischemic stroke patients 
do not receive. Because hypertension control is a cornerstone 
of stroke secondary prevention, interventions are needed 
which will improve hypertension management poststroke.
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